Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Other Benefit Plans (Summary of Non Vested Awards) (Details)

v3.20.1
Stock-Based Compensation and Other Benefit Plans (Summary of Non Vested Awards) (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Restricted Stock [Member]  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Outstanding at January 1, 2020 | shares 343,000
Awards granted | shares 0
Awards vested | shares (125,000)
Outstanding at March 31, 2020 | shares 218,000
Weighted Average Grant Price, Outstanding at January 1, 2020 $ 1.52
Weighted Average Grant Price, Awards granted
Weighted Average Grant Price, Awards vested 1.37
Weighted Average Grant Price, Unvested awards forfeited
Weighted Average Grant Price, Outstanding at March 31, 2020 $ 1.61
Stock Appreciation Rights (SARs) [Member]  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Outstanding at January 1, 2020 | shares 3,418,000
Awards granted | shares
Awards exercised | shares
Unvested awards forfeited | shares
Vested shares expired | shares
Outstanding at March 31, 2020 | shares 3,418,000
Exercisable at March 31, 2020 | shares 1,813,000
Weighted Average Grant Price, Outstanding at January 1, 2020 $ 1.30
Weighted Average Grant Price, Awards granted
Weighted Average Grant Price, Awards exercised
Weighted Average Grant Price, Unvested awards forfeited
Weighted Average Grant Price, Vested shares expired
Weighted Average Grant Price, Outstanding at March 31, 2020 1.30
Weighted Average Exercise Price Per Share, Exercisable at March 31, 2020 $ 1.13
Term (in years), Outstanding at March 31, 2020 2 years 11 months 15 days
Term (in years), Exercisable at March 31, 2020 2 years 8 months 26 days
Aggregate Intrinsic Value, Outstanding at March 31, 2020 | $ $ 73
Aggregate Intrinsic Value, Exercisable at March 31, 2020 | $ $ 47